CEFALY Technology
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Seraing, Liege, Belgium, Europe
Region: Liege
Country: BE
Continent: Europe
About
Cefaly is a clinically validated migraine treatment device that uses neuromodulation to provide drug-free relief for acute attacks and prevention. It is designed for home use and FDA-cleared as a wearable neurological device to reduce migraine pain and attacks, targeting nerve pathways involved in migraine. The company operates primarily in the United States with a presence in Europe and other regions, and it offers patient support, clinical studies, and a connected CeCe app for migraine management.
Cefaly Technology develops and sells the CEFALY DUAL, a wearable neurological device that uses transcutaneous electrical nerve stimulation to treat migraine pain. The FDA-cleared device targets the trigeminal nerve to provide drug-free relief for acute attacks and prevention. The company serves patients globally, primarily in the United States and Europe, offering the hardware alongside a connecte
Cefaly Technology
2004
for_profit
active
Industries
Primary Industry: Retail
Categories
Funding & Financials
Private Equity
10m-50m
private
Investors
Founders
Pierre Rigaux
Pierre-Yves Muller
Leadership
Technology Stack
Products
CEFALY Migraine Treatment Device: A wearable, FDA-cleared medical device that uses external trigeminal nerve stimulation to provide drug-free acute and preventive migraine treatment.
CeCe Migraine Management App: A mobile app that tracks migraine attacks and treatment sessions, helping users monitor and optimize their migraine management.
CEFALY Self-Adhesive Electrodes: Reusable adhesive electrodes that attach to the forehead to deliver electrical stimulation from the CEFALY device to the trigeminal nerve.